“Georgia CTSA Clinical Research Centers are absolutely essential to the success of any NIH study, especially ones that are fairly complicated, such as the challenge study,” says Nadine Rouphael, M.D., M.Sc., Professor of Medicine, Division of Infectious Diseases, Emory, and Director of the Hope Clinic, the clinical arm of Emory Vaccine Center. “I think without the GCRCs’ support, we would not have been in a place where a human challenge study could be done.”
Over the past decade, Dr. Rouphael has maintained a long-standing partnership with the Georgia CTSA Clinical Research Centers (GCRCs) with respect to performing and completing her ongoing clinical trials. Most recently, two of those clinical trials include her important work on the Influenza Human Challenge Model study, examining how the immune system responds to the flu virus (H3N2) during and after infection and how the flu virus is transmitted in the environment, as well as the Phase 2 Shigella Vaccine and Challenge study, testing a Phase 2 experimental vaccine against the Shigella bacteria, a common bacterial cause of diarrhea worldwide…
Read the full article here.
